Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Parkinson’s Research Buoyed by Alzheimer’s Advances
BioSpace
Oct 02 2023
https://gaintherapeutics.com/
Related Posts
Post navigation
Previous Post
Allosteric drugs: A differentiated small molecule approach
Next Post
Dosing Underway for Phase 1 Parkinson Trial of GBA1-Targeting Agent GT-02287
Latest Articles
Clear Filters
September 3, 2024
Gain readies for Phase 1b trial of Parkinson’s therapy GT-02287
https://parkinsonsnewstoday.com/news/gain-readies-phase-1b-trial-parkinsons-therapy-gt-02287/
Read More
August 30, 2024
Gain Therapeutics reports positive data from Phase I Parkinson’s treatment trial
https://www.clinicaltrialsarena.com/news/gain-therapeutics-parkinsons-trial/
Read More
August 30, 2024
In the clinic for Aug. 30, 2024
https://www.bioworld.com/articles/712024-in-the-clinic-for-aug-30-2024?v=preview
Read More
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives